Schizophrenia Research
Volume 77, Issue 2 , Pages 215-227, 15 September 2005

Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection

  • Robert A. Lasser

      Affiliations

    • Global Medical Strategy, Johnson & Johnson Pharmaceutical Services, LLC, Raritan, NJ 08869, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 908 927 3490; fax: +1 908 252 0912.
    • ,
  • Cynthia A. Bossie

      Affiliations

    • Medical Affairs Division, Janssen Pharmaceutica Products, L.P., 1125 Trenton-Harbourton Road, Office A20305, Titusville, NJ 08560-0200, USA
    • ,
  • Georges M. Gharabawi

      Affiliations

    • Medical Affairs Division, Janssen Pharmaceutica Products, L.P., 1125 Trenton-Harbourton Road, Office A20305, Titusville, NJ 08560-0200, USA
    • ,
  • John M. Kane

      Affiliations

    • The Zucker Hillside Hospital, 5-59 263rd Street, Glen Oaks, NY 11004, USA

Received 23 August 2004; received in revised form 3 March 2005; accepted 14 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(05)00116-7

doi:10.1016/j.schres.2005.03.006

Schizophrenia Research
Volume 77, Issue 2 , Pages 215-227, 15 September 2005

Article Tools

* Image Usage & Resolution